3WHO. Influenza [ EB/DL] . Fifty - sixth world health assembly 2003;http: //www. who. int/influenza.
4WHO. Influenza Pandemic Plan [ EB/DL] . The Role of WHO and Guidelines for National and Regional Planning. 1999.
5WHO. WHO Guidelines on the Use of Vaccines and Antivirals during Influenza Pandemics [ EB/DL] .WHO/CDS/CSR/RMD/2004.8..
6Patrick J Gavin, Richard B Thomson, Jr. Review of Rapid Diagnostic Tests for Influenza [ EB/DL] . Clinical and Applied Immunology Reviews, 2003; 4: 151- 172.
7N. Kawai et al. The clinical outcomes of anti - influenza drug therapy:a Japanese multi - center study of the 2002 - 2003 influenza season [J].International Gongress Series, 2004; 1263:507-510.
8WHO, Geneva. Estimating the impact of the next influenza pandemic:enhancing preparedness [ EB/DL ] . 2004; http: //www.who.int/csr/disease/influenza/preparedness. 2004-12-08.
9Hilleman, Maurice R. Realities and enigmas of human viral influenza:pathogenesis, epidemiology and control [J] .Vaccine 2002; 20 (25-26): 3068-3087.
10Wright PF, Webster RG. Orthomyxoviruses [M] .In: Knipe DM,Howley PM, editors. Fields virology, vol. 1.4th ed. Philadelphia: Lippincott Williams and Wilkins, 2001. p. 1533 -79.
